Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

ARS-1620 MeSH Supplementary Concept Data 2025


MeSH Supplementary
ARS-1620
Unique ID
C000629713
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000629713
Entry Term(s)
1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one sulfane
Registry Numbers
0
Heading Mapped to
*Piperazines
*Quinazolines
Frequency
6
Note
covalent S-IIP G12C inhibitor for targeting of KRAS G12C mutant tumors
Source
Cell. 2018 Jan 25;172(3):578-589.e17.
Date of Entry
2019/02/04
Revision Date
2019/02/04
ARS-1620 Preferred
1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one sulfane Broader
page delivered in 0.005s